Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource | Zendy

Brian K. Link | Zendy; Matthew J. Maurer | Zendy; Grzegorz S. Nowakowski | Zendy; Stephen M. Ansell | Zendy; William R. Macon | Zendy; Sergei Syrbu | Zendy; Susan L. Slager | Zendy; Carrie A. Thompson | Zendy; David J. Inwards | Zendy; Patrick B. Johnston | Zendy; Joseph P. Colgan | Zendy; Thomas E. Witzig | Zendy; Thomas M. Habermann | Zendy; James R. Cerhan | Zendy

Open Access

Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource

Author(s) -

Brian K. Link,

Matthew J. Maurer,

Grzegorz S. Nowakowski,

Stephen M. Ansell,

William R. Macon,

Sergei Syrbu,

Susan L. Slager,

Carrie A. Thompson,

David J. Inwards,

Patrick B. Johnston,

Joseph P. Colgan,

Thomas E. Witzig,

Thomas M. Habermann,

James R. Cerhan

Publication year - 2013

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2012.48.3990

Subject(s) - medicine , rituximab , follicular lymphoma , epidemiology , mortality rate , lymphoma , surgery

This study sought to characterize transformation incidence and outcome for patients with follicular lymphoma (FL) in a prospective observational series begun after diffusion of rituximab use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research